Neonatal hyperthyrotropinemia is associated with low birth weight: a twin study
Amnon Zung1, Arie Yehieli, Shlomo Almashanu
1Pediatric Endocrinology Unit, Kaplan Medical Center, affiliated with the Hebrew University of Jerusalem, Rehovot 76100, Israel. amzung2@bezeqint.net
European Journal of Endocrinology
|November 28, 2012
Summary
Neonatal hyperthyrotropinemia (HT) is linked to lower birth weight (BW) in twins. Most infants recover quickly, and perinatal stress markers did not show a significant association with HT.
Area of Science:
- Endocrinology
- Neonatal Medicine
- Pediatrics
Background:
- Neonatal hyperthyrotropinemia (HT) has conflicting associations with prematurity and low birth weight (BW).
- Understanding the factors influencing neonatal thyroid function is crucial for early diagnosis and management.
Purpose of the Study:
- To investigate the relationship between neonatal HT and BW.
- To assess the recovery rate of neonatal HT.
- To explore the potential association between perinatal stress and HT.
Main Methods:
- A retrospective twin study utilizing a neonatal screening database.
- Evaluation of thyroid-stimulating hormone (TSH) and thyroxine (T4) levels within twin pairs.
- Analysis of birth weight, birth order, gender, and 17-hydroxyprogesterone (17OHP) as a stress marker.
Main Results:
- Neonatal HT was observed in 7.2% of twin pairs, with higher prevalence in smaller twins (64%) and discordant pairs (76%).
- Seventy-five percent of affected twins showed recovery within weeks.
- Elevated TSH levels were significantly associated with lower BW in both HT and normal neonates, particularly in discordant twins.
Conclusions:
- Low birth weight is a significant factor associated with elevated TSH levels in neonates, irrespective of HT diagnosis.
- Most cases of neonatal HT exhibit a rapid recovery pattern.
- Perinatal stress, indicated by 17OHP levels, did not demonstrate a clear association with neonatal HT in this twin cohort.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...


